neffy
Commercial- Indications
- Life-threatening allergies
Company intelligence / Profile preview
Renaissance Pharma
Lakewood, New Jersey, United Statesrenpharm.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
01
Overview
The UK-based entity’s lead program is Hu14.18K322A (“Hu14.18”), a humanized anti-GD2 monoclonal antibody immunotherapy for high-risk neuroblastoma. Phase II data showed an overall survival rate of 86% when combined with induction chemotherapy in newly diagnosed patients; all patients showed evidence of clinical benefit. The program is pending advancement to further trials and regulatory submissions. The US-based contract manufacturing arm specializes in nasal sprays and sterile injectables with extensive experience supporting client products through all phases including commercial launch.
- Therapeutic areas
- OncologyImmunologyNeurology
- Modalities
- Monoclonal antibodySmall moleculeBiologicNasal spray formulation
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
St. Jude Children’s Research HospitalTiziana Life Sciences
Beyond the preview
Go deeper on Renaissance Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Renaissance Pharma.